Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05256381 |
|---|---|
| Brief Title: | A Study of SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid Tumors |
| First Submitted : | February 8, 2022 |
| First Submitted that Met QC Criteria : | February 24, 2022 |
| First Posted : | February 25, 2022 |
| Last Update Submitted that Met QC Criteria : | March 6, 2024 |
| Last Update Posted : | March 8, 2024 |